Navigation Links
Nu Skin Enterprises to Announce Fourth Quarter and Year-End 2008 Results
Date:1/21/2009

PROVO, Utah, Jan. 21 /PRNewswire-FirstCall/ -- Nu Skin Enterprises, Inc. (NYSE: NUS) today announced that it will release fourth quarter and year-end 2008 financial results prior to the market opening on Friday, Feb. 6, 2009.

Truman Hunt, president and chief executive officer, will host a conference call with the investment community later that same day beginning at 11 a.m. (EST). During the call, participants can expect to hear management review past results and discuss future plans and expectations.

The webcast of the conference call, including the financial information to be presented, will be available on the investor section of the company's Web site at www.nuskinenterprises.com. A replay of the webcast will be available at the same location through Friday, Feb. 20, 2009.

The Company

For 25 years, Nu Skin Enterprises, Inc. has been demonstrating its tradition of innovation through its comprehensive anti-aging product portfolio, independent business opportunity and corporate social responsibility initiatives. Nu Skin's scientific leadership in both skin care and nutrition has established Nu Skin as a premier anti-aging company, evidenced in its patent-pending ageLOC(TM) technology and flagship products including the Galvanic Spa(R) System II, Tru Face(R) Essence Ultra, LifePak(R) nano and the g3 nutrition beverage. A global direct selling company, Nu Skin operates in 48 markets throughout Asia, the Americas and Europe and has more than 750,000 independent sales representatives. Nu Skin Enterprises is traded on the New York Stock Exchange under the symbol "NUS." More information is available at http://www.nuskinenterprises.com.


'/>"/>
SOURCE Nu Skin Enterprises, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Nu Skin Enterprises Receives Broader Direct Selling Authorization in China
2. FFF Enterprises Launches New MyFluVaccine Website
3. BioMedical Enterprises, Inc. (BME) Announces the Appointment of Kenneth I. Moch as President and Chief Executive Officer
4. Universal Music Enterprises (UMe) and Body By Jake Global Create the Worlds First Digital Fitness Music Label
5. XStor Medical Systems Announces the Release of its Imaging Platform for Connectivity Between Healthcare Enterprises
6. Brian Rubin Joins TrailBlazer Health Enterprises Board of Directors
7. Nu Skin Enterprises Offers 2009 Guidance During Annual Investor Day
8. FFF Enterprises Unveils ‘The 8 Critical Steps to Guaranteed Channel Integrity' at the American Society of Health-System Pharmacists (ASHP) Midyear Meeting in Orlando
9. Nu Skin Enterprises to Hold 2008 Investor Day
10. Nu Skin Enterprises Names Brett Nelson President of Nu Skin Japan
11. Nu Skin Enterprises Opens the Czech Republic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2009)... NEW ORLEANS, Dec. 6 Onyx Pharmaceuticals, ... safety data from the pivotal Phase 2b 003-A1 ... carfilzomib is well-tolerated in heavily pre-treated relapsed and ... today at the ASH/ASCO Joint Symposium at the ... Hematology (ASH) in New Orleans. Enrollment in this ...
(Date:12/6/2009)... the community, in cooperation with the Greater VA Healthcare System in ... year,s attendance is expected to soar to more than 5,000 veterans, ... ... (PRWEB) December 6, 2009 -- Volunteer organizations and members of ... West Los Angeles, will once again create a holiday party. This ...
(Date:12/5/2009)... December 5 The first Football,for Hope Centre ... opened its doors,today (5 December 2009). FIFA President ... Helen Zille, 2010 FIFA World Cup Organising Committee,South ... Association,President Kirsten Nematandani and Executive Mayor of the ...
(Date:12/5/2009)... advanced Technology Center helps companies develop and test their cleaning processes. ... a variety of industries and solve problems for customers relating to ... ... December 5, 2009 -- Midbrook, Inc , a Jackson, MI-based ...
(Date:12/4/2009)... NEW YORK, Dec. 4 Care Investment Trust Inc. ... that its Board of Directors has declared a dividend of $0.17 ... December 22, 2009 to common shareholders of record on December 14, ... ,, Care Investment Trust Inc. is a real estate investment and ...
Breaking Medicine News(10 mins):Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 2Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 3Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 4Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 5Health News:17th Annual Event Honoring 5,000 + Veterans, Military Personnel to Include Real Life “Heroes” 2Health News:17th Annual Event Honoring 5,000 + Veterans, Military Personnel to Include Real Life “Heroes” 3Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 2Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 3Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 2Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 3Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2
... 15 The Houston Chapter of the American,Association ... with a donation of $35,000 to advance cancer ... Neuroblastoma Research Program led by surgeon,Eugene Kim. The ... to,block blood vessel growth in neuroblastoma, a deadly ...
... play role in immune, inflammatory processes, study says ... psoriasis have higher levels of the obesity-related hormone leptin ... Taiwanese study included 77 psoriasis patients and a control ... The researchers gathered health information about the participants and ...
... The board of directors of,Eli Lilly and Company (NYSE: ... in,its quarterly dividend. The board declared a dividend for ... common stock. This raises the,annual indicated rate to $1.96 ... company has increased the dividend payment. , ...
... Children & High School Student Volunteers Collaborate in Musical ... N.J. and HAWTHORNE, N.J., Dec. 15 ... performing arts organization and conservatory bringing together individuals with ... is pleased to announce that its members, all children ...
... are "addicted" to a family of proteins produced by ... halts cell proliferation in the deadliest cancer of the ... of California, Berkeley scientists at the American Society for ... in San Francisco. , In 30-60 percent of human ...
... ViroPharma Incorporated (Nasdaq: VPHM ) today provided the ... , The Food and Drug Administration (FDA) ... The new draft guidance is open for public comment, ... generic applicants beyond the in vitro dissolution testing ...
Other Medicine News:Health News:Drilling Engineers Donate $35,000 to Texas Children's Hospital 2Health News:Obesity-Related Hormone Tied to Psoriasis 2Health News:Sharing The Arts & Ridgewood High School Present Musical Production of Charlie and The Chocolate Factory 2Health News:Stopping ovarian cancer by blocking proteins coded by notorious gene 2Health News:ViroPharma Provides Update on Vancocin(R) 2Health News:ViroPharma Provides Update on Vancocin(R) 3Health News:ViroPharma Provides Update on Vancocin(R) 4
(Date:12/4/2009)... Hospira, Inc. (NYSE: HSP ), a leading ... the launch of its next-generation 50 mL and 100 ... and now offers a complete size range (50 mL ... product. The launch of the 50 mL and 100 ...
(Date:12/4/2009)... Md., Dec. 4 PharmAthene, Inc. (NYSE Amex: ... countermeasures against biological and chemical threats, announced today ... study demonstrating the effectiveness of Valortim® in an ... (NZW) rabbit. The data are being presented ...
(Date:12/4/2009)... 4 Axsun Technologies, Inc., a wholly-owned subsidiary of ... initial development and successful testing of a novel integrated ... this proprietary optical engine design raises the bar on ... for swept source OCT light sources. This approach ...
Breaking Medicine Technology:Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 3Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 3Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 4Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 5Abbott Hosts Conference Call for Third Quarter Earnings 14252 1Oncolytics Biotech 28R 29 Inc Announces Start of Enrolment in U S Phase 2 Melanoma Cancer Clinical Trial 5057 1Oncolytics Biotech 28R 29 Inc Announces Start of Enrolment in U S Phase 2 Melanoma Cancer Clinical Trial 5057 2Oncolytics Biotech 28R 29 Inc Announces Start of Enrolment in U S Phase 2 Melanoma Cancer Clinical Trial 5057 3Oncolytics Biotech 28R 29 Inc Announces Start of Enrolment in U S Phase 2 Melanoma Cancer Clinical Trial 5057 4Babies see it coming 58252 1Babies see it coming 58252 2
... WASHINGTON, June 20, 2007 /PRNewswire-USNewswire/ -- The,following is a ... and executive order: , East Room , 2:39 P.M. ... America is a,nation that leads the world in science ... in,medicine that could save lives and cure diseases. America ...
... 2007 /PRNewswire-USNewswire/ -- Democratic,National Committee Chairman Howard Dean ... again put politics ahead,of science by vetoing the ... legislation, providing federal funding for life-saving,embryonic stem cell ... and passed both the House and Senate with,bipartisan ...
Other Medicine Technology:Remarks by President Bush on Stem Cell Veto and Executive Order 2Remarks by President Bush on Stem Cell Veto and Executive Order 3Remarks by President Bush on Stem Cell Veto and Executive Order 4Remarks by President Bush on Stem Cell Veto and Executive Order 5Remarks by President Bush on Stem Cell Veto and Executive Order 6Dean: President Bush Has Turned His Back on the American People 2
... The Mayfield 2000 series radiolucent headrest system ... intraoperative digital subtraction angiography. This system is ... skull clamp and the Mayfield radiolucent base ... designed for patient positioning in the prone ...
Bunnel hand drill with Jacobs chuck, chuck size 4 mm....
Hudson hand drill with extension piece....
Sighting and visualization system of the digital operating suite. The platform that links navigation, and intra-operative imaging to form the ultimate surgical workstation....
Medicine Products: